Evidence map›Paper›PMID 33799418›Full record

ArticleCancers2021

p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair.

Keane K Y Lai, Xiaohui Hu, Keisuke Chosa, Cu Nguyen, David P Lin, Keith K Lai, Nobuo Kato, Yusuke Higuchi, Sarah K Highlander, Elizabeth Melendez and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Keane K Y LaiDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Xiaohui HuDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.ORCID 0000-0002-3483-2847
Keisuke ChosaDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Cu NguyenDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
David P LinDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Keith K LaiDepartment of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA.
Nobuo KatoThe Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.
Yusuke HiguchiDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Sarah K HighlanderClinical Microbiome Service Center and Pathogen and Microbiome Division, Translational Genomics Research Institute, Flagstaff, AZ 86005, USA.
Elizabeth MelendezDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Yoshihiro EriguchiDepartment of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0000-0002-5803-230X
Patrick T FuegerCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Andre J OuelletteDepartment of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Nyam-Osor ChimgeDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Masaya OnoDepartment of Clinical Proteomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Michael KahnDepartment of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
City of Hope · USUniversity of Southern California · USCleveland Clinic · USOsaka Research Institute of Industrial Science and Technology · JPTranslational Genomics Research Institute · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Efficacy of Novel Wnt Modulator in Colon CancerR01CA166161 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAHN, MICHAEL, LENZ, HEINZ JOSEF · 2013 to 2017
$2.3M
Mechanisms of beta-catenin signaling in alveolar epithelial cell differentiationR01HL112638 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA, KAHN, MICHAEL · 2013 to 2016
$2.2M
Stearoyl-CoA Desaturase in Alcohol-Promoted Liver TumorigenesisK08AA025112 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, KEANE · 2017 to 2021
$978k
Modulation of Wnt Signaling in Models of Multiple SclerosisR21NS074392 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GILMORE, WENDY · 2012 to 2013
$444k
Innate enteric immunity during induced Paneth cell deficiencyR21AI105057 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 2013 to 2014
$440k
NIAAA NIH HHS K08 AA025112NIH HHS K08AA025112NIH HHS P30CA033572NIH HHS R01CA166161NIH HHS R01HL112638NIH HHS R21AI105057NIH HHS R21NS074392Rotary Coins for Alzheimer's Research Trust (CART) N/A
6 · The paper itself

Abstract

Differential usage of Kat3 coactivators, CBP and p300, by β-catenin is a fundamental regulatory mechanism in stem cell maintenance and initiation of differentiation and repair. Based upon our earlier pharmacologic studies, p300 serine 89 (S89) is critical for controlling differential coactivator usage by β-catenin via post-translational phosphorylation in stem/progenitor populations, and appears to be a target for a number of kinase cascades. To further investigate mechanisms of signal integration effected by this domain, we generated p300 S89A knock-in mice. We show that S89A mice are extremely sensitive to intestinal insult resulting in colitis, which is known to significantly increase the risk of developing colorectal cancer. We demonstrate cell intrinsic differences, and microbiome compositional differences and differential immune responses, in intestine of S89A versus wild type mice. Genomic and proteomic analyses reveal pathway differences, including lipid metabolism, oxidative stress response, mitochondrial function and oxidative phosphorylation. The diverse effects on fundamental processes including epithelial differentiation, metabolism, immune response and microbiome colonization, all brought about by a single amino acid modification S89A, highlights the critical role of this region in p300 as a signaling nexus and the rationale for conservation of this residue and surrounding region for hundreds of million years of vertebrate evolution.

Indexed as

CBPcolitiscolorectal cancerIBDp300Wnt

Identifiers

PMID33799418
PMCPMC7999107
OpenAlexW3136719407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.